Pub Date : 2018-11-09DOI: 10.15406/aowmc.2018.08.00261
Mina T. Kelleni
serotonin plays a role in obesity pathogenesis, but also peripheral serotonin was suggested to play an important role in obesity, and evidence from animal studies has demonstrated 5-HT ability to regulate glucose and lipid metabolism by accelerating energy consumption in skeletal muscle. Further, gut-derived 5-HT was likely suggested to be an important driver of pathogenesis in human obesity as well as in dysglycemia4,5 and several genetic polymorphisms in tryptophan hydroxylase and 5-HT receptors were shown to have strong associations with obesity. Moreover, peripheral 5-HT was shown to suppress the adaptive thermo genesis in brown adipose tissue and the peripheral serotonergic system was marked as a therapeutic target for both obesity and diabetes.6 Lorcaserin, 5-HT2 receptor agonist, and its potential under development more specific congeners with lower adverse effects, suppress the appetite and reduce body weight gain and are considered as promising therapeutic tools for obesity7 while antagonism of 5-HT2c receptor has been identified as a main cause of second generation antipsychotics induced weight gain and obesity.8 On the other hand, obesity increases peripheral serotonin and inhibiting serotonin signaling or its synthesis in adipose tissue may be an effective treatment for obesity and its comorbidities.9
{"title":"Role of central and peripheral serotonin in obesity: what to expect in the near pharmacotherapy future?","authors":"Mina T. Kelleni","doi":"10.15406/aowmc.2018.08.00261","DOIUrl":"https://doi.org/10.15406/aowmc.2018.08.00261","url":null,"abstract":"serotonin plays a role in obesity pathogenesis, but also peripheral serotonin was suggested to play an important role in obesity, and evidence from animal studies has demonstrated 5-HT ability to regulate glucose and lipid metabolism by accelerating energy consumption in skeletal muscle. Further, gut-derived 5-HT was likely suggested to be an important driver of pathogenesis in human obesity as well as in dysglycemia4,5 and several genetic polymorphisms in tryptophan hydroxylase and 5-HT receptors were shown to have strong associations with obesity. Moreover, peripheral 5-HT was shown to suppress the adaptive thermo genesis in brown adipose tissue and the peripheral serotonergic system was marked as a therapeutic target for both obesity and diabetes.6 Lorcaserin, 5-HT2 receptor agonist, and its potential under development more specific congeners with lower adverse effects, suppress the appetite and reduce body weight gain and are considered as promising therapeutic tools for obesity7 while antagonism of 5-HT2c receptor has been identified as a main cause of second generation antipsychotics induced weight gain and obesity.8 On the other hand, obesity increases peripheral serotonin and inhibiting serotonin signaling or its synthesis in adipose tissue may be an effective treatment for obesity and its comorbidities.9","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84637906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-11-07DOI: 10.15406/AOWMC.2018.08.00260
K. Aljabri, S. Bokhari, Muneera Alshareef, Patan Murthuza Khan, Hesham Abu Alsaoud, Mohammad M Jalal, Rania F Safwat, Rehab Borae, ari K Aljabri
Metabolic syndrome (MetS) is a cluster of metabolic factors. MetS was initially observed in 1923 by Kyln, who described the clustering of hypertension, hyperglycaemia and gout as the syndrome.1 The first official definition of MetS put forward by a working group of the World Health Organization (WHO) in 1999, a number of different definitions have been proposed. There have been several definitions of MetS, but the most commonly used criteria for definition at present are from the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III), the International Diabetes Federation (IDF), and the World Health Organization (WHO).2−4
{"title":"Frequency of underweight in Saudi adults","authors":"K. Aljabri, S. Bokhari, Muneera Alshareef, Patan Murthuza Khan, Hesham Abu Alsaoud, Mohammad M Jalal, Rania F Safwat, Rehab Borae, ari K Aljabri","doi":"10.15406/AOWMC.2018.08.00260","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00260","url":null,"abstract":"Metabolic syndrome (MetS) is a cluster of metabolic factors. MetS was initially observed in 1923 by Kyln, who described the clustering of hypertension, hyperglycaemia and gout as the syndrome.1 The first official definition of MetS put forward by a working group of the World Health Organization (WHO) in 1999, a number of different definitions have been proposed. There have been several definitions of MetS, but the most commonly used criteria for definition at present are from the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III), the International Diabetes Federation (IDF), and the World Health Organization (WHO).2−4","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89910894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-19DOI: 10.15406/AOWMC.2018.08.00259
T. DeLorenzo
{"title":"Why are we seeing so many more children diagnosed with food allergies?","authors":"T. DeLorenzo","doi":"10.15406/AOWMC.2018.08.00259","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00259","url":null,"abstract":"","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84347086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-15DOI: 10.15406/aowmc.2018.08.00258
Beverly M Copel, S. McWhinney, A. Osonkie
Obesity in adults and children has been a problem throughout modern history but only in the past 30years has it increased to epidemic proportions. It is evident that during the past three decades the proportion of obese children became nearly tripled across all age groups. Estimation from the 2011-2012 National Health and Nutrition Examination Survey (NHANES) indicated that 17% of children and adolescents ages 2-19 years are overweight.1
{"title":"Evaluation of meals served in state registered childcare settings","authors":"Beverly M Copel, S. McWhinney, A. Osonkie","doi":"10.15406/aowmc.2018.08.00258","DOIUrl":"https://doi.org/10.15406/aowmc.2018.08.00258","url":null,"abstract":"Obesity in adults and children has been a problem throughout modern history but only in the past 30years has it increased to epidemic proportions. It is evident that during the past three decades the proportion of obese children became nearly tripled across all age groups. Estimation from the 2011-2012 National Health and Nutrition Examination Survey (NHANES) indicated that 17% of children and adolescents ages 2-19 years are overweight.1","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81583452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-11DOI: 10.15406/AOWMC.2018.08.00256
A. Mendes, Elisabete Mendes, Hugo Caldeira, Laura Gomes, Patrícia Lima, Eva Menino, Stefanie Francisco, A. Corte
Studies about the risks of adolescents in rural and urban areas so far are still very rudimentary, so this integrative review is very attractive and bearing in mind that in the near future these young people will be the future of the communities. Community actions aimed at the promotion, health protection and identification of community care needs in their different dimensions require that health professionals have a proactive approach. Adolescence is a phase of life characterized by biological, physical, psychological and social transformations that can affect daily activities of life. It has been found that young people do not follow the daily recommendations of physical activity proposed by the World Health Organization (2016).
{"title":"Health risk of adolescents in the rural and urban environment: integrative review","authors":"A. Mendes, Elisabete Mendes, Hugo Caldeira, Laura Gomes, Patrícia Lima, Eva Menino, Stefanie Francisco, A. Corte","doi":"10.15406/AOWMC.2018.08.00256","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00256","url":null,"abstract":"Studies about the risks of adolescents in rural and urban areas so far are still very rudimentary, so this integrative review is very attractive and bearing in mind that in the near future these young people will be the future of the communities. Community actions aimed at the promotion, health protection and identification of community care needs in their different dimensions require that health professionals have a proactive approach. Adolescence is a phase of life characterized by biological, physical, psychological and social transformations that can affect daily activities of life. It has been found that young people do not follow the daily recommendations of physical activity proposed by the World Health Organization (2016).","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"56 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87037751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-11DOI: 10.15406/AOWMC.2018.08.00257
Kooshana Vinay Kumar, Penthala Prashanth Reddy, aru Siva Subrahmanyam, E. Venkateshwarlu, aru Sheshagiri Sharvana Bhava
Hypertension is defined as high blood pressure or a long term medical condition in which the arterial blood pressure is continuously elevated.1 It is also explained as sustained diastolic BP more than 90mmHG accompanied by the elevated systolic BP more than 140mmHg.2 Diabetes mellitus is a disorder related with a wide variety of disorders in metabolism, the principal feature is hyperglycaemia caused by inadequate insulin action.3 Most deaths(43%) fall out below 70years of age. 422million people across the globe in 2014 had diabetes-with a 8.5% prevalence in adults.1.5million deaths in 2012 occurred due to diabetes. In 2012 among both genders it is the eighth major cause of death and fifth prime cause of death in woman. About 2,82,000 intensive care room visits for adult population aged 18 years and above encountered hypoglycaemia as an initial diagnosis and diabetes as secondary diagnosis in 2012.4 In the past 30 years Diabetes prevalence consistently inclining and is increasing most rapidly in nations with low and middle income. Increasing concomitant risk factors like being overweight or obese are seen. Diabetes mellitus is a main reason for blindness and kidney failure, legs amputation and other chronic consequences that affect primarily on quality of life.5
{"title":"Efficacy of azilsartan and telmisartan in patients with type 2 diabetes and hypertension","authors":"Kooshana Vinay Kumar, Penthala Prashanth Reddy, aru Siva Subrahmanyam, E. Venkateshwarlu, aru Sheshagiri Sharvana Bhava","doi":"10.15406/AOWMC.2018.08.00257","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00257","url":null,"abstract":"Hypertension is defined as high blood pressure or a long term medical condition in which the arterial blood pressure is continuously elevated.1 It is also explained as sustained diastolic BP more than 90mmHG accompanied by the elevated systolic BP more than 140mmHg.2 Diabetes mellitus is a disorder related with a wide variety of disorders in metabolism, the principal feature is hyperglycaemia caused by inadequate insulin action.3 Most deaths(43%) fall out below 70years of age. 422million people across the globe in 2014 had diabetes-with a 8.5% prevalence in adults.1.5million deaths in 2012 occurred due to diabetes. In 2012 among both genders it is the eighth major cause of death and fifth prime cause of death in woman. About 2,82,000 intensive care room visits for adult population aged 18 years and above encountered hypoglycaemia as an initial diagnosis and diabetes as secondary diagnosis in 2012.4 In the past 30 years Diabetes prevalence consistently inclining and is increasing most rapidly in nations with low and middle income. Increasing concomitant risk factors like being overweight or obese are seen. Diabetes mellitus is a main reason for blindness and kidney failure, legs amputation and other chronic consequences that affect primarily on quality of life.5","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87587101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-02DOI: 10.15406/AOWMC.2018.08.00255
M. Míguez, Calonie M. K. Gray, Clery Quiros, C. Perez
Relying on evidence that smokers tend to weigh less than nonsmokers, tobacco companies have used several strategies to take advantage of, and manipulate, people’s concern with weight.1,2 Their goal became the addition of active agents to target “non-smokers who are more concerned with losing weight than with contracting respiratory or blood circulatory illnesses. [...] (Bates no. 2056159412).2 While initially focusing on appetite suppressants, later companies began considering “Specific Appetite Inducers”.2 Documents indicated that they were experimenting with “special herbs or medications in a cigarette form as appetite stimulants or possibly for tension release”.2 The list included tartaric acid, 2-Acethylpyridine, catecholamine, menthol, mariolide, propylene glycol and reserpine. They were aware that appetite can be strongly influenced by both aromatic and taste characteristics of the compounds, and inquired about menthol.3 Note worthy, experts indicated that menthol had reached inconclusive effects. Yet, menthol’s other characteristics (e.g. odor, taste, and flavor) let to its inclusion and marketing.2,4 Although several decades have passed since the introduction of mentholated cigarettes to the market, the burgeoning literature is notable for the scarcity of studies examining the plausible effect of mentholated cigarettes on weight.5 A recent insurgence of concern over the safety of this additive, and its potential relationship with weight gain, has prompted further research.6
{"title":"The effect of cigarette type on anthropometrics and weight of PLWH","authors":"M. Míguez, Calonie M. K. Gray, Clery Quiros, C. Perez","doi":"10.15406/AOWMC.2018.08.00255","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00255","url":null,"abstract":"Relying on evidence that smokers tend to weigh less than nonsmokers, tobacco companies have used several strategies to take advantage of, and manipulate, people’s concern with weight.1,2 Their goal became the addition of active agents to target “non-smokers who are more concerned with losing weight than with contracting respiratory or blood circulatory illnesses. [...] (Bates no. 2056159412).2 While initially focusing on appetite suppressants, later companies began considering “Specific Appetite Inducers”.2 Documents indicated that they were experimenting with “special herbs or medications in a cigarette form as appetite stimulants or possibly for tension release”.2 The list included tartaric acid, 2-Acethylpyridine, catecholamine, menthol, mariolide, propylene glycol and reserpine. They were aware that appetite can be strongly influenced by both aromatic and taste characteristics of the compounds, and inquired about menthol.3 Note worthy, experts indicated that menthol had reached inconclusive effects. Yet, menthol’s other characteristics (e.g. odor, taste, and flavor) let to its inclusion and marketing.2,4 Although several decades have passed since the introduction of mentholated cigarettes to the market, the burgeoning literature is notable for the scarcity of studies examining the plausible effect of mentholated cigarettes on weight.5 A recent insurgence of concern over the safety of this additive, and its potential relationship with weight gain, has prompted further research.6","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75809568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-10-01DOI: 10.15406/AOWMC.2018.08.00254
Hirides S, Verveniotis N, Galanopoulou R, Metaxas P, Polyzou A, Hirides P
According to latest literature laparoscopic repair of large parietal wall defects is a well-accepted and safe option for class II and class III obesity patients. Apart from cardiorespiratory and anesthesiological parameters, main concerns with such patients include the relatively higher risks of wound infections and recurrencies as well as postoperative hemorrhage and port-site hernias. However, advantages over classic – open repairs are well demarcated in the literature. Recent introduction of robotics in bariatric as well as hernia surgery brings up new hopes for expansion of the indications to patients with very large incisional hernias and loss of domain. Our aim in this paper is to present a single surgeon’s technique with laparoscopic and robotic parietal wall defect repairs in morbidly obese patients and review latest literature for main concerns of a novice team.
{"title":"Laparoscopic and robotic ventral hernia repair in obese and morbidly obese patients: initial experience and review of the literature","authors":"Hirides S, Verveniotis N, Galanopoulou R, Metaxas P, Polyzou A, Hirides P","doi":"10.15406/AOWMC.2018.08.00254","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00254","url":null,"abstract":"According to latest literature laparoscopic repair of large parietal wall defects is a well-accepted and safe option for class II and class III obesity patients. Apart from cardiorespiratory and anesthesiological parameters, main concerns with such patients include the relatively higher risks of wound infections and recurrencies as well as postoperative hemorrhage and port-site hernias. However, advantages over classic – open repairs are well demarcated in the literature. Recent introduction of robotics in bariatric as well as hernia surgery brings up new hopes for expansion of the indications to patients with very large incisional hernias and loss of domain. Our aim in this paper is to present a single surgeon’s technique with laparoscopic and robotic parietal wall defect repairs in morbidly obese patients and review latest literature for main concerns of a novice team.","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78895413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-09-26DOI: 10.15406/aowmc.2018.08.00253
A. Catena, Nerea Ruiz Sacedón, E. O. Murillo, Reyes Balanzá Chancosa
The aim of this study is to evaluate obstetric complications and perinatal outcomes in 7 pregnant women with morbid obesity (BMI ? 40.0 kg/m²) compared to pregnant women with 8 normal weight (BMI 18.5-24.9 kg/m²). It is a retrospective case-control study undertaken by 9 the Department of Obstetrics at Hospital Universitario Doctor Peset, Valencia (Spain) between 10 May 2008 and July 2016. A total of 50 patients were included in each study group. Morbidly 11 obese pregnant patients had a higher rate of nulliparity (P = 0.03), chronic hypertension (P = 12 0.008), preeclampsia (P = 0.03), gestational diabetes (P = 0.013) and delivery by caesarean 13 section (P = 0.04) compared to control patients with normal weight. A closer monitoring of 14 morbidly obese pregnant women is recommended to prevent, reduce and properly handle the 15 complications that may arise during pregnancy, both for the mother and the fetus.
{"title":"Pregnant women with morbid obesity: pregnancy and perinatal outcomes","authors":"A. Catena, Nerea Ruiz Sacedón, E. O. Murillo, Reyes Balanzá Chancosa","doi":"10.15406/aowmc.2018.08.00253","DOIUrl":"https://doi.org/10.15406/aowmc.2018.08.00253","url":null,"abstract":"The aim of this study is to evaluate obstetric complications and perinatal outcomes in 7 pregnant women with morbid obesity (BMI ? 40.0 kg/m²) compared to pregnant women with 8 normal weight (BMI 18.5-24.9 kg/m²). It is a retrospective case-control study undertaken by 9 the Department of Obstetrics at Hospital Universitario Doctor Peset, Valencia (Spain) between 10 May 2008 and July 2016. A total of 50 patients were included in each study group. Morbidly 11 obese pregnant patients had a higher rate of nulliparity (P = 0.03), chronic hypertension (P = 12 0.008), preeclampsia (P = 0.03), gestational diabetes (P = 0.013) and delivery by caesarean 13 section (P = 0.04) compared to control patients with normal weight. A closer monitoring of 14 morbidly obese pregnant women is recommended to prevent, reduce and properly handle the 15 complications that may arise during pregnancy, both for the mother and the fetus.","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78197753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-09-05DOI: 10.15406/AOWMC.2018.08.00252
R. Marks
Despite the paucity of data pertaining to the current topics of interest, some of these research efforts do show women tend to be more vulnerable than men in terms of becoming or being obese, especially with regards to extreme obesity,6 although reasons for this are not clear. However, because women also show greater levels of disability from complications related to obesity, some studies have specifically focused on examining gender-related factors that may explain women’s higher rates of obesity. In this regard some data point to the presence of depression or depressive symptoms, given that for every age group, women with depression appear more likely to be obese than women without depression. The proportion of adults with obesity also rose as the severity of depressive symptoms increased in a related analysis.8 Other data showed 55% of adults taking antidepressant medications, still reported moderate to severe depressive symptoms, and were obese, suggesting other obesity associated factors should be explored. One that has also been explored is alcohol.
{"title":"Obesity, depression, and alcohol linkages among women","authors":"R. Marks","doi":"10.15406/AOWMC.2018.08.00252","DOIUrl":"https://doi.org/10.15406/AOWMC.2018.08.00252","url":null,"abstract":"Despite the paucity of data pertaining to the current topics of interest, some of these research efforts do show women tend to be more vulnerable than men in terms of becoming or being obese, especially with regards to extreme obesity,6 although reasons for this are not clear. However, because women also show greater levels of disability from complications related to obesity, some studies have specifically focused on examining gender-related factors that may explain women’s higher rates of obesity. In this regard some data point to the presence of depression or depressive symptoms, given that for every age group, women with depression appear more likely to be obese than women without depression. The proportion of adults with obesity also rose as the severity of depressive symptoms increased in a related analysis.8 Other data showed 55% of adults taking antidepressant medications, still reported moderate to severe depressive symptoms, and were obese, suggesting other obesity associated factors should be explored. One that has also been explored is alcohol.","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79026353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}